IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein

International Immunology

Volumn 10, Issue 5, 1998, Pages 703-708

  Okuda, Yoshinobu ^b   Sakoda, Saburo ^b   Bernard, Claude C A ^a   Fujimura, Harutoshi ^b   Saeki, Yukihiko ^b   Kishimoto, Tadamitsu ^b   Yanagihara, Takehiko ^b  

^a LA TROBE UNIVERSITY   (Australia)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Autoimmunity; Cytokines; Knockout mouse; Neuroimmunology

Indexed keywords

INTERLEUKIN 6; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE RESISTANCE; HISTOLOGY; INFLAMMATORY CELL; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; SPINAL CORD;

EID: 0031920882     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.5.703     Document Type: Article

References (38)

1. Kishimoto, T. 1989. The biology of interleukin-6. Blood 74:1.
2. Hirano, T., Akira, S., Taga, T. and Kishimoto, T. 1990. Biological and clinical aspect of interleukin 6. Immunol. Today 11:443.
3. Bansil, S., Cook, S. D. and Rohowsky-Kochan, C. 1995 Multiple sclerosis: immune mechanism and update on current therapies. Ann. Neurol. 37:87.
4. Nishimoto, N., Yoshizaki, K., Eiraku, N., Machigashira, K., Tagoh, H., Ogata, A., Kuritani, T., Osame, M. and Kishimoto, T. 1990. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-1-associated myelopathy/tropical spastic paraparesis. J. Neurol. Sci. 97:183.
5. Maimone, D., Gregory, S., Arnason, B. G. W. and Reder, A. T. 1991. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J. Neuroimmunol. 32:67.
6. Frei, K., Fredrikson, S., Fontana, A. and Link, H. 1991. Interleukin-6 is elevated in plasma in multiple sclerosis. J. Neuroimmunol 31:147.
7. Woodroofe, M. N. and Cuzner, M. L. 1993. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 5:583.
8. Maimone, D., Guazzi, G. C. and Annunziata, P. 1997. IL-6 detection in multiple sclerosis brain. J. Neurol. Sci. 146:59.
9. Navikas, V., Matusevicius, D., Söderström, M., Fredrikson, S., Kivisäkk, P., Ljungdahl, Å, Höjeberg, B. and Link, H. 1996. Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. J. Neuroimmunol. 64:63.
10. Kennedy, M. K., Torrance, D. S., Picha, K. S. and Mohler, K. M. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496.
11. Okuda, Y., Nakatsuji, Y., Fujimura, H., Esumi, H., Ogura, T., Yanagihara, T. and Sakoda, S. 1995. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62:103.
12. Diab, A., Zhu, J., Xiao, B. G., Mustafa, M. and Link, H. 1997. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats. J. Neuropathol. Exp. Neurol. 56:641.
13. Okuda, Y., Sakoda, S., Fujimura, H. and Yanagihara, T. 1996. Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells, Immunopharmacology 35:141.
14. Willenborg, D. O., Fordham, S. A., Cowden, W. B. and Ramshaw, I. A. 1995. Cytokines and murine autoimmune encephalomyelitis: Inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol. 41:31.
15. Gijbels, K., Brocke, S., Abrams, J. S. and Steinman, L 1995. Administration of neutralizing antibodies to interleukin-6(IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol. Med. 1:795.
16. Johns, T. G., Kerlero de Rosbo, N., Menson, K. K., Abo, S., Gonzales, M. F. and Bernard, C. C. A. 1995. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154:5536.
17. b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur. J. Immunol. 25:1951.
18. Bernard, C. C. A., Johns, T. G., Slavin, A., Ichikawa, M., Ewing, C., Liu, J. and Bettadapura, J. 1997. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75:77.
19. Bettadapura, J., Menon, K. K., Moritz, S., Liu, J. and Bernard, C. C. A. 1998. Expression, purification and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein. J. Neurochem., in press.
20. Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A. J., Old, L. and Bernard, C. C. A. 1998. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4:78.
21. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H. and Köhler, G. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339.
22. Tsukada, I. and Fujinami, R. S. 1996. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J. Neuropathol. Exp. Neurol. 55:673.
23. Wolf, S. D., Dittel, B. N., Hardardottir, F. and Janeway, C. A., Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184:2271.
24. Schluesener, H. J., Sobel, R. A., Linington, C. and Weiner, H. L. 1987. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139:4016.
25. Linington, C., Berger, T., Perry, L., Weerth, S., Hinze-Selch, D., Zhang, Y., Lu, H., Lassmann, H. and Wakerle, H. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23:1364.
26. Ichikawa, M., Johns, T. G., Liu, J. and Bernard, C. C. A. 1996. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. J. Immunol. 157:919.
27. Lassmann, H., Zimprich, F., Rössler, K. and Vass, K. 1991. Inflammation in the nervous system. Basic mechanisms and immunological concepts. Rev. Neurol. 147:763.
28. Jayaraman, S., Martin, C. A. and Dorf, M. E. 1990. Enhancement of in vivo cell-mediated immune responses by three distinct cytokines. J. Immunol. 144:942.
29. Mihara, M., Ikuta, M., Koishihara, Y. and Ohsugi, Y. 1991. Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis. Eur. J. Immunol. 21:2327.
30. Aderka, D., Le, J. and Vilcek, J. 1989. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143:3517.
31. Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S. C. and Dinarello, C. A. 1990. Correlations and interactions in the production of interleukin-6(IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75:40.
32. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183:1345.
33. Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B. A. and Mucke, L. 1993. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl Acad. Sci. USA 90:10061.
34. Ferber, I. A., Brocke, S., Edwards, C. T., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D. and Fathman, C. G. 1996. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:5.
35. Willenborg, D. O., Fordham, S., Bernard, C. C. A., Cowden, W. B. and Ramshaw, I. A. 1996. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:3223.
36. Körner, H., Riminton, D. S., Strickland, D. H., Lemckert, F. A., Pollard, J. D. and Sedgwick, J. D. 1997. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186:1585.
37. Suen, W. E., Bergman, C. M., Hjelmström, P. and Ruddle, N. H. 1997. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 186:1233.
38. Frei, K., Eugster, H., Bopst, M., Constantinescu, C. S., Lavi, E. and Fontana, A. 1997. Tumor necrosis factor α and lymphotoxin a are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185:2177.